_id

690dad38ccc777a4e85d09f2

Ticker

ALGS

Name

Aligos Therapeutics Inc

Exchange

NASDAQ

Address

One Corporate Drive, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.aligos.com

Description

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). The company also develops ALG-000184, a capsid assembly modulator, which is completed Phase 1b clinical trial to treat chronic hepatitis B (CHB); and ALG-125755, a siRNA drug candidate, which is in Phase I clinical trial for the treatment of CHB. In addition, it develops ALG-097558, which is in Phase 2 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH; license agreement with Emory University to provide hepatitis B virus capsid assembly modulator technology; license agreement with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; and research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors. It also has a clinical collaboration with Xiamen Amoytop Biotech Co., Ltd. The company was incorporated in 2018 and is headquartered in South San Francisco, California.

Last Close

11.51

Volume

49216

Current Price

13.295

Change

15.508253692441357

Last Updated

2025-11-28T12:06:47.948Z

Image

data:image/webp;base64,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

Ipo Date

2020-10-16T00:00:00.000Z

Market Cap

60674316

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8979999999999999

Sentiment Sources

2

Rating

4.6667

Target Price

80.25

Strong Buy

2

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

741000

Cost Of Revenue

-

Gross Profit

741000

Operating Expenses

29102000

Operating Income

-28361000

Interest Expense

-

Pretax Income

-31481000

Net Income

-31537000

Eps

-3.041312845754414

Dividends Per Share

-

Shares Outstanding

5353582

Income Tax Expense

56000

EBITDA

-30783000

Operating Margin

-3827.395411605938

Total Other Income Expense Net

-3120000

Cash

41946000

Short Term Investments

57150000

Receivables

-

Inventories

-

Total Current Assets

103435000

Property Plant Equipment

5616000

Total Assets

109764000

Payables

4651000

Short Term Debt

3563000

Long Term Debt

-

Total Liabilities

37931000

Equity

71833000

Depreciation

220000

Change In Working Capital

1532000

Cash From Operations

-24345000

Capital Expenditures

193000

Cash From Investing

47683000

Cash From Financing

-53000

Net Change In Cash

23285000

PE

-

PB

1.919214954477747

ROE

-43.90321996853814

ROA

-28.731642432855946

FCF

-24538000

Fcf Percent

-33.11470985155196

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

5

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

1

Momentum Investing Score

6.5

Net Net Investing Score

5.5

Quality Investing Score

2

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

741000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

741000

Quarters > 0 > income Statement > operating Expenses

29102000

Quarters > 0 > income Statement > operating Income

-28361000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-31481000

Quarters > 0 > income Statement > net Income

-31537000

Quarters > 0 > income Statement > eps

-3.041312845754414

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

10369535

Quarters > 0 > income Statement > income Tax Expense

56000

Quarters > 0 > income Statement > EBITDA

-30783000

Quarters > 0 > income Statement > operating Margin

-3827.395411605938

Quarters > 0 > income Statement > total Other Income Expense Net

-3120000

Quarters > 0 > balance Sheet > cash

41946000

Quarters > 0 > balance Sheet > short Term Investments

57150000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

103435000

Quarters > 0 > balance Sheet > property Plant Equipment

5616000

Quarters > 0 > balance Sheet > total Assets

109764000

Quarters > 0 > balance Sheet > payables

4651000

Quarters > 0 > balance Sheet > short Term Debt

3563000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

37931000

Quarters > 0 > balance Sheet > equity

71833000

Quarters > 0 > cash Flow > net Income

-31537000

Quarters > 0 > cash Flow > depreciation

220000

Quarters > 0 > cash Flow > change In Working Capital

1532000

Quarters > 0 > cash Flow > cash From Operations

-24345000

Quarters > 0 > cash Flow > capital Expenditures

193000

Quarters > 0 > cash Flow > cash From Investing

47683000

Quarters > 0 > cash Flow > cash From Financing

-53000

Quarters > 0 > cash Flow > net Change In Cash

23285000

Quarters > 0 > ratios > PE

-3.041312845754414

Quarters > 0 > ratios > PB

1.919214954477747

Quarters > 0 > ratios > ROE

-43.90321996853814

Quarters > 0 > ratios > ROA

-28.731642432855946

Quarters > 0 > ratios > FCF

-24538000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-33.11470985155196

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

965000

Quarters > 1 > income Statement > cost Of Revenue

259000

Quarters > 1 > income Statement > gross Profit

706000

Quarters > 1 > income Statement > operating Expenses

19273000

Quarters > 1 > income Statement > operating Income

-18567000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-15678000

Quarters > 1 > income Statement > net Income

-15863000

Quarters > 1 > income Statement > eps

-1.5324911700376385

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

10351120

Quarters > 1 > income Statement > income Tax Expense

185000

Quarters > 1 > income Statement > EBITDA

-15419000

Quarters > 1 > income Statement > operating Margin

-1924.041450777202

Quarters > 1 > income Statement > total Other Income Expense Net

2889000

Quarters > 1 > balance Sheet > cash

18661000

Quarters > 1 > balance Sheet > short Term Investments

104284000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

127944000

Quarters > 1 > balance Sheet > property Plant Equipment

6122000

Quarters > 1 > balance Sheet > total Assets

134706000

Quarters > 1 > balance Sheet > payables

3937000

Quarters > 1 > balance Sheet > short Term Debt

3540000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

32840000

Quarters > 1 > balance Sheet > equity

101866000

Quarters > 1 > cash Flow > net Income

-15863000

Quarters > 1 > cash Flow > depreciation

259000

Quarters > 1 > cash Flow > change In Working Capital

930000

Quarters > 1 > cash Flow > cash From Operations

-15504000

Quarters > 1 > cash Flow > capital Expenditures

109000

Quarters > 1 > cash Flow > cash From Investing

-39421000

Quarters > 1 > cash Flow > cash From Financing

-177000

Quarters > 1 > cash Flow > net Change In Cash

-55102000

Quarters > 1 > ratios > PE

-1.5324911700376385

Quarters > 1 > ratios > PB

1.3509722615985706

Quarters > 1 > ratios > ROE

-15.572418667661436

Quarters > 1 > ratios > ROA

-11.776015916143304

Quarters > 1 > ratios > FCF

-15613000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-16.179274611398963

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

311000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

311000

Quarters > 2 > income Statement > operating Expenses

19554000

Quarters > 2 > income Statement > operating Income

-19243000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

43131000

Quarters > 2 > income Statement > net Income

43088000

Quarters > 2 > income Statement > eps

4.94713189087147

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

8709693

Quarters > 2 > income Statement > income Tax Expense

43000

Quarters > 2 > income Statement > EBITDA

-18733000

Quarters > 2 > income Statement > operating Margin

-6187.459807073955

Quarters > 2 > income Statement > total Other Income Expense Net

62374000

Quarters > 2 > balance Sheet > cash

73763000

Quarters > 2 > balance Sheet > short Term Investments

64098000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

143205000

Quarters > 2 > balance Sheet > property Plant Equipment

6862000

Quarters > 2 > balance Sheet > total Assets

150699000

Quarters > 2 > balance Sheet > payables

4460000

Quarters > 2 > balance Sheet > short Term Debt

3487000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

34254000

Quarters > 2 > balance Sheet > equity

116445000

Quarters > 2 > cash Flow > net Income

43088000

Quarters > 2 > cash Flow > depreciation

510000

Quarters > 2 > cash Flow > change In Working Capital

-3835000

Quarters > 2 > cash Flow > cash From Operations

-20909000

Quarters > 2 > cash Flow > capital Expenditures

43000

Quarters > 2 > cash Flow > cash From Investing

-44067000

Quarters > 2 > cash Flow > cash From Financing

101742000

Quarters > 2 > cash Flow > net Change In Cash

36766000

Quarters > 2 > ratios > PE

4.94713189087147

Quarters > 2 > ratios > PB

0.9944211295890765

Quarters > 2 > ratios > ROE

37.0028768946713

Quarters > 2 > ratios > ROA

28.592094174480252

Quarters > 2 > ratios > FCF

-20952000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-67.36977491961414

Quarters > 2 > health Score

73

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

629000

Quarters > 3 > income Statement > cost Of Revenue

671000

Quarters > 3 > income Statement > gross Profit

629000

Quarters > 3 > income Statement > operating Expenses

21192000

Quarters > 3 > income Statement > operating Income

-20563000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-82123000

Quarters > 3 > income Statement > net Income

-82150000

Quarters > 3 > income Statement > eps

-13.076928954469683

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

6282056

Quarters > 3 > income Statement > income Tax Expense

27000

Quarters > 3 > income Statement > EBITDA

-19892000

Quarters > 3 > income Statement > operating Margin

-3269.1573926868045

Quarters > 3 > income Statement > total Other Income Expense Net

-61560000

Quarters > 3 > balance Sheet > cash

36997000

Quarters > 3 > balance Sheet > short Term Investments

19942000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

62141000

Quarters > 3 > balance Sheet > property Plant Equipment

7326000

Quarters > 3 > balance Sheet > total Assets

70094000

Quarters > 3 > balance Sheet > payables

2571000

Quarters > 3 > balance Sheet > short Term Debt

3458000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

99067000

Quarters > 3 > balance Sheet > equity

-28973000

Quarters > 3 > cash Flow > net Income

-82150000

Quarters > 3 > cash Flow > depreciation

671000

Quarters > 3 > cash Flow > change In Working Capital

-390000

Quarters > 3 > cash Flow > cash From Operations

-18403000

Quarters > 3 > cash Flow > capital Expenditures

28000

Quarters > 3 > cash Flow > cash From Investing

19972000

Quarters > 3 > cash Flow > cash From Financing

97000

Quarters > 3 > cash Flow > net Change In Cash

1666000

Quarters > 3 > ratios > PE

-13.076928954469683

Quarters > 3 > ratios > PB

-2.882681618058192

Quarters > 3 > ratios > ROE

283.53984744417215

Quarters > 3 > ratios > ROA

-117.1997603218535

Quarters > 3 > ratios > FCF

-18431000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-29.302066772655007

Quarters > 3 > health Score

31

Valuation > metrics > PE

-3.041312845754414

Valuation > metrics > PB

1.919214954477747

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-43.90321996853814

Profitability > metrics > ROA

-30.489679508870303

Profitability > metrics > Net Margin

-42.56005398110661

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.5280442136622444

Risk > metrics > Interest Coverage

-40.63180515759312

Risk > final Score

-115

Risk > verdict

High

Liquidity > metrics > Current Ratio

12.592524957389822

Liquidity > metrics > Quick Ratio

12.592524957389822

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

90

Prev Valuations > 2

50

Prev Profitabilities > 0

0

Prev Profitabilities > 1

100

Prev Profitabilities > 2

40

Prev Risks > 0

-227

Prev Risks > 1

59

Prev Risks > 2

29

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:05.017Z